IL-6 trans-signaling, which is mediated via the s-IL-6R, is critically involved in several inflammatory and autoimmune diseases including inflammatory bowel disease, rheumatoid arthritis, and asthma, as well as colitis-associated cancer [23]. Here, IL6R is linked to inflammatory bowel disease.